Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding
- 1 August 1986
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 379 (2), 294-299
- https://doi.org/10.1016/0006-8993(86)90783-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Decreased tuberoinfundibular and pituitary dopamine and dihydroxyphenylacetic acid concentrations in rats with estrogen-induced pituitary tumorsNeuroscience Letters, 1985
- Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptorsPsychoneuroendocrinology, 1984
- [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsyEuropean Journal of Pharmacology, 1984
- Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s DiseaseCanadian Journal of Neurological Sciences, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Effect of prolactin and estradiol on rat striatal dopamine receptorsLife Sciences, 1982
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brainMolecular and Cellular Endocrinology, 1979
- Receptor basis for dopaminergic supersensitivity in Parkinson's diseaseNature, 1978
- Extension of Multiple Range Tests to Group Means with Unequal Numbers of ReplicationsBiometrics, 1956